Evidence map›Paper›PMID 35464398›Full record

ArticleFrontiers in immunology2022

Case Report: X-Linked SASH3 Deficiency Presenting as a Common Variable Immunodeficiency.

Moisés Labrador-Horrillo, Clara Franco-Jarava, Marina Garcia-Prat, Alba Parra-Martínez, María Antolín, Sandra Salgado-Perandrés, Aina Aguiló-Cucurull, Mónica Martinez-Gallo, Roger Colobran

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Moisés Labrador-HorrilloAllergy Section, Internal Medicine Department, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Research Institute (VHIR) RETIC ARADyal, Vall d'Hebron Barcelona Hospital, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Clara Franco-JaravaImmunology Division, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
Marina Garcia-PratJeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Alba Parra-MartínezJeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
María AntolínDepartment of Clinical and Molecular Genetics, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
Sandra Salgado-PerandrésImmunology Division, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
Aina Aguiló-CucurullImmunology Division, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
Mónica Martinez-GalloImmunology Division, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
Roger ColobranImmunology Division, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
Vall d'Hebron Institut de Recerca · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SASH3 is a lymphoid-specific adaptor protein. In a recent study, SASH3 deficiency was described as a novel X-linked combined immunodeficiency with immune dysregulation, associated with impaired TCR signaling and thymocyte survival in humans. The small number of patients reported to date showed recurrent sinopulmonary, cutaneous and mucosal infections, and autoimmune cytopenia. Here we describe an adult patient previously diagnosed with common variable immunodeficiency (CVID) due to low IgG and IgM levels and recurrent upper tract infections. Two separate, severe viral infections drew our attention and pointed to an underlying T cell defect: severe varicella zoster virus (VZV) infection at the age of 4 years and bilateral pneumonia due type A influenza infection at the age of 38. Genetic testing using an NGS-based custom-targeted gene panel revealed a novel hemizygous loss-of-function variant in the

Indexed as

Common Variable ImmunodeficiencyCOVID-19Primary Immunodeficiency DiseasesVaccinesHumansMaleSARS-CoV-2Vaccinescombined immunodeficiencycommon variable immunodeficiencygeneticsinborn errors of immunitymutationprimary immunodeficienciesSASH3 deficiency

Identifiers

PMID35464398
PMCPMC9027814
OpenAlexW4226088535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.